Schema-Root.org logo

 

  cross-referenced news and research resources about

 Cephalon pharmaceuticals

Schema-Root.org logo
images:  google   yahoo YouTube
spacer

updated Wed. February 27, 2019

-
Defendants include Purdue Pharma, Teva Pharmaceuticals, Cephalon, Johnson & Johnson, Janssen Pharmaceuticals, Ortho-McNeil-Janssen Pharmaceuticals, Endo Pharmaceuticals, Allergan, Actavis, Watson Laboratories, Insys Therapeutics, Inc., Mallinckrodt, Mckesson Corporation, Cardinal Health ...

“We are filing suit because the pharmaceutical drug manufacturers and wholesale drug distributors have refused and failed to fulfill their specific and legal ... Defendants in the case include manufacturers Purdue Pharma LP, Cephalon Inc., Janssen Pharmaceuticals Inc., Endo Health Solutions Inc., Allergan ...
Inc., Teva Pharmaceuticals USA Inc., Cephalon Inc., Johnson & Johnson, Janssen Pharmaceuticals Inc., Endo Health Solutions Inc,. ... “The City of Fostoria spends millions of dollars each year to provide and pay for health care, services, pharmaceutical care and other necessary services and programs on ...
The lawsuit names as defendants 25 individuals and businesses from nine major pharmaceutical companies: Purdue Pharma L.P., Endo Pharmaceuticals, Allergan, Teva, Cephalon, Janssen, AmerisourceBergen, Cardinal Health and McKesson. "This case is about one thing: corporate greed. Defendants ...
Direct purchaser plaintiffs filed a case against Cephalon, Inc., (the branded manufacturer of Provigil) and four generic pharmaceutical companies, alleging that Cephalon executed anticompetitive reverse-payment settlements with each of the ... Retailers of pharmaceuticals were excluded from the class.
... it says were too ready to fill even questionable prescriptions for the drugs. The county filed suit Monday in federal court against 19 companies in the opioid suit, including manufacturers such as Purdue Pharma, Cephalon and Teva Pharmaceuticals and pharmacies such as Walgreens, Walmart and CVS.
At a hearing today, Teva Pharmaceutical Industries (TEVA -0.9%) says it "responded robustly" to charges from the European Commission's competition watchdog that it entered into an illegal "pay-for-delay" deal with Cephalon to delay selling a generic version of its sleep disorder drug Provigil (modafinil).
Teva Pharmaceuticals USA Inc. and subsidiary Cephalon Inc. want to get out of state court in Pennsylvania and into federal court. The drug ... Dana Elfin is the Senior Legal Editor for Bloomberg BNA's Pharmaceutical Law and Industry Report and Bloomberg BNA's Medical Device and Law Report.
Broward County is going after opioid manufacturers it blames for the epidemic that has ravaged communities — and large pharmacy chains that it says were too ready to fill even questionable prescriptions for the drugs. The county filed suit Monday in federal court against 19 companies in the opioid suit, ...
Israeli pharmaceutical company Teva “robustly” responded to the European Commission's charge of anti-competitive behaviour at a hearing earlier this week. In July last year the European Commission called out Teva over a pay-for-delay drug deal with competitor Cephalon. At the time, Margrethe ...


 

news and opinion


 


 


 


 


schema-root.org

    teva
      cephalon